ReviewViszeralmedizin2015
Palliative Endoscopic Therapy of Esophageal Cancer.
Review in Viszeralmedizin, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 9 citations in OpenAlex.
- Comprehensive review of materials, applications, and future innovations in biodegradable esophageal stents.Frontiers in bioengineering and biotechnology · 2023Review
- Endoscopic Management of Esophageal Cancer.Cancers · 2022Review
- Optimal Management of Dysphagia in Patients with Inoperable Esophageal Cancer: Current Perspectives.Cancer management and research · 2022Review
- Salvage therapy of bleeding esophageal tumor by fully covered self-expandable metallic stent: A case report.SAGE open medical case reports · 2021Article
- Efficacy of Chemoradiotherapy on Health-Related Quality of Life in Esophageal Cancer Patients with Dysphagia.Materia socio-medica · 2019Article
- Resection of early esophageal neoplasms: The pendulum swings from surgical to endoscopic management.World journal of gastrointestinal endoscopy · 2019Review
- Small Bowel Perforation Secondary to Esophageal Stent Migration: A Comparative Review of Six Cases.Cureus · 2018Article
- Stereotactic radiotherapy in the treatment of local recurrences of esophageal cancer.Oncology letters · 2017Article
- Expression ofOncology letters · 2016Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis is a review of endoscopic therapy in the setting of palliative management of patients suffering from esophageal cancer (EC). Unfortunately, many cases of EC present in a stage of disease in which curative therapy is not possible. The maintenance of quality of life includes the ability to swallow and of oral feeding, pain control, and the prevention of bleeding.
methodsA review of the current literature was performed.
resultsMany endoscopic methods are available for the management of dysphagia, of which dilation, endoluminal tumor destruction, stenting, and brachytherapy are the most common.
conclusionSurgical palliation should be avoided as much as possible since the alternatives show at least the same efficacy and have fewer complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.